↓ Skip to main content

Mechanisms Underlying Clinical Efficacy of Angiotensin II Type 2 Receptor (AT2R) Antagonist EMA401 in Neuropathic Pain: Clinical Tissue and in Vitro Studies

Overview of attention for article published in Molecular Pain, June 2015
Altmetric Badge

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mechanisms Underlying Clinical Efficacy of Angiotensin II Type 2 Receptor (AT2R) Antagonist EMA401 in Neuropathic Pain: Clinical Tissue and in Vitro Studies
Published in
Molecular Pain, June 2015
DOI 10.1186/s12990-015-0038-x
Pubmed ID
Authors

Uma Anand, Yiangos Yiangou, Marco Sinisi, Michael Fox, Anthony MacQuillan, Tom Quick, Yuri E Korchev, Chas Bountra, Tom McCarthy, Praveen Anand

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 2%
Unknown 54 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 15%
Researcher 6 11%
Student > Bachelor 6 11%
Student > Master 6 11%
Other 3 5%
Other 9 16%
Unknown 17 31%
Readers by discipline Count As %
Medicine and Dentistry 9 16%
Biochemistry, Genetics and Molecular Biology 7 13%
Agricultural and Biological Sciences 6 11%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Neuroscience 2 4%
Other 10 18%
Unknown 16 29%